Tinzaparin is an attractive option for a low molecular weight heparin (LMWH) that can be considered for elderly patients with chronic kidney disease where there are concerns for drug accumulation, an Australian pilot study suggests. The drug can be used without dose adjustment as it has less renal clearance than other LMWH and is therefore ...
Tinzaparin a novel LMWH option for patients with impaired renal function
By Michael Woodhead
20 Aug 2020